GE Capital Aviation Services is the world's pre-eminent aviation finance company for commercial jets, engines and helicopters.
Location: United States, Connecticut, Norwalk
Employees: 11-50
Total raised: $80M
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | The Jordan... | thejordanc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.10.2018 | - | $80M | - |
Mentions in press and media 20
| Date | Title | Description |
| 21.02.2025 | Vår Energi signs new helicopter contract | Vår Energi signs new helicopter contract Fri, Feb 21, 2025 12:00 CET Report this content Sandnes, Norway 21 February 2025: Vår Energi ASA (OSE:VAR) has awarded Norwegian company Lufttransport RW AS the assignment of operating two new helico... |
| 14.02.2022 | AerCap N : Milestone Aviation Signs Lease Agreements with Omni Helicopters International for 11 Aircraft | February 14, 2022 Download as PDF Milestone Aviation Signs Lease Agreements with Omni Helicopters International for 11 Aircraft DUBLIN - February 14, 2022 - The Milestone Aviation Group Limited ("Milestone"), the global leader in ... |
| 07.12.2021 | AerCap N : Milestone to deliver two S-92s to CHC for Norwegian Search and Rescue missions | December 7, 2021 Download as PDF Milestone to deliver two S-92s to CHC for Norwegian Search and Rescue missions DUBLIN - The Milestone Aviation Group Limited ("Milestone"), the global leader in helicopter leasing, today announced ... |
| 13.07.2021 | AstraZeneca : HUTCHMED Announces First Commercial Sale of ORPATHYS® in China, Triggering a US$25 million Milestone Payment from AstraZeneca | HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) announces the first commercial sale in China of ORPATHYS® (savolitinib), HUTCHMED’s or... |
| 13.07.2021 | HUTCHMED Limited Announces First Commercial Sale of ORPATHYS® in China, Triggering a USD 25 million Milestone Payment from AstraZeneca | HUTCHMED (China) Limited announced the first commercial sale in China of ORPATHYS® (savolitinib), HUTCHMEDs oral, potent, and highly selective small molecule inhibitor of MET, a receptor tyrosine kinase, which occurred on July 12, 2021. Th... |
| 18.06.2021 | JACOBIO PHARMACEUTICALS GROUP CO., LTD. Jacobio Announces First Two Patients Dosed in SHP2 Combination Study, Triggering $20 Million Milestone Payment | Jacobio Pharmaceuticals announced that the first two patients have been dosed in the Phase 1/2a clinical trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib respectively, thereby tr... |
| 17.06.2021 | Jacobio Announces First Two Patients Dosed in SHP2 Combination Study, Triggering US$20 Million Milestone Payment | |
| 09.03.2021 | Branded Content Project Announces $1M Milestone in Content Series Sponsorship Sales Revenue for Local Media Participants | |
| 11.02.2021 | MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte | ROCKVILLE, MD, Feb. 11, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today an... |
| 08.02.2021 | HCL Technologies Announces INR 700 Cr Bonus For Employees As Company Crosses $10 Bn Revenue Milestone | February 8, 2021 2 min read Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Noida-based multinational technology company HCL Technologies (H... |
Show more